Chloroethyl Benzo[d]Imidazole Ester Preparation With Stoichiometric Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing method for preparing 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl esters using oxalyl chloride and dimethylformamide results in undesirable yellow coloration and impurities, which are difficult to remove, and lacks precise control over the reaction stoichiometry.
Innovation Solution
A method using chloromethylenedimethyliminium chloride in a stoichiometric or superstoichiometric ratios to convert 4-[5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl esters, allowing for better control over the reaction and minimizing impurities, with the option to form a novel formylated derivative.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If oxalyl chloride is used in superstoichiometric excess (≥2.6 mol, particularly ≥3.0 mol) to ensure complete conversion, then the yield of 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl ester is improved, but the reaction produces undesirable yellow coloration and difficult-to-remove impurities
Solution Approach 1:
The patent changes the molar ratio parameter from superstoichiometric (≥2.6:1) to substantially stoichiometric (1.95:1 to 2.05:1), which eliminates the yellow coloration and impurities while maintaining high conversion efficiency. This precise parameter control resolves the contradiction between complete conversion and product purity.
Solution Approach 2:
The patent uses dimethylcarbamoyl chloride as a substitute reagent that replicates the chlorination function of oxalyl chloride but without producing the harmful yellow byproducts. This alternative chemical pathway achieves the same transformation goal while avoiding the harmful effects.
2Productivity
If oxalyl chloride reaction with dimethylformamide is used to convert hydroxyethyl groups to chloroethyl groups, then the desired product is obtained in good yield, but the reaction becomes difficult to control regarding completeness and interfering moisture
Solution Approach 1:
The patent removes dimethylformamide from the reaction system entirely, using only dimethylcarbamoyl chloride as the reagent. This eliminates the problematic intermediate formation and moisture sensitivity issues associated with the oxalyl chloride-dimethylformamide system, while maintaining effective chlorination capability.
Solution Approach 2:
The patent employs dimethylcarbamoyl chloride as a single-use reagent that performs the chlorination function and is then discarded, avoiding the need for complex intermediate handling and purification steps required by the oxalyl chloride-dimethylformamide system. This simplifies the process and improves reliability.
3Object-generated harmful factors
If activated carbon treatment is applied to remove yellow coloration, then some impurities are reduced, but the yellow coloration remains difficult to remove completely
Solution Approach 1:
The patent performs preliminary action by precisely controlling the stoichiometry of the chlorination reaction from the outset, preventing the formation of yellow byproducts before they occur. This proactive approach eliminates the need for subsequent activated carbon treatment entirely, making the purification process trivial.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high yields of 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl esters with reduced impurities and enables the production of a novel formylated derivative with potential anti-tumor activity, offering improved occupational safety and reaction control.
Implementation Method 1
The reactants used are 4-[5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl esters, the hydroxyethyl groups of which can be converted into chloroethyl groups by reaction with oxalyl chloride
Implementation Method 2
The in-situ reaction of oxalyl chloride with dimethylformamide used here is difficult to control with regard to the completeness of the reaction
Implementation Method 3
Ester hydrolysis can cause 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl esters to be converted to 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid
Data Source
AI summary
A method for preparing a 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1 H-benzo[d]imidazol-2-yl]butyric acid alkyl ester, wherein 1 mol of 4-[5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzo[d]imidazol-2-yl]butyric acid alkyl ester is reacted with 2.0 to 2.2 mol of chloromethylenedimethyliminium chloride or with >2.2 to 5 mol of chloromethylenedimethyliminium chloride to prepare a by-product in the form of a 4-[5-[bis(2-chloroethyl)amino]-4-formyl-1-methyl-1 H-benzo[d]imidazol-2-yl]butyric acid alkyl ester. The alkyl ester can be hydrolyzed to form 4-[5-[bis(2-chloroethyl)amino]-4-formyl-1-methyl-1H benzo[d]imidazol-2-yl]butyric acid that is usable in the field of medicine.